| RS1295444626 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS1295446479 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1295448612 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Inborn genetic diseases |
| RS1295449344 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1295465247 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1295466248 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 1, Inborn genetic diseases |
| RS1295477856 |
KCNQ3
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1295485913 |
MRE11
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder 1 |
| RS1295524564 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1295527713 |
ATAD3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1295547257 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS1295555837 |
PEX10
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1295558388 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1295566242 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS1295567170 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1295577366 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1295595912 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1295614525 |
TCIRG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1295630463 |
MVK
|
Health Risk |
Likely pathogenic |
Mevalonic aciduria, Mevalonic aciduria |
| RS1295637847 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS1295645330 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1295662769 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1295669283 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS1295669429 |
SGCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1295678117 |
DOCK2
|
Health Risk |
Conflicting classifications of pathogenicity |
DOCK2 deficiency, DOCK2 deficiency |
| RS1295688123 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS1295689490 |
AGRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital myasthenic syndrome 8 |
| RS1295703239 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1295732689 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1295769704 |
GATA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrioventricular septal defect 4, Cardiovascular phenotype |
| RS1295790880 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart defects, dysmorphic facial features |
| RS1295791827 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, FG syndrome |
| RS1295802121 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1295805735 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS1295812149 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation deficiency, Charcot-Marie-Tooth Neuropathy X |
| RS1295875245 |
PPFIA3
|
Health Risk |
Likely pathogenic |
PPFIA3-related disorder, PPFIA3-related disorder |
| RS1295893226 |
CEP290
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1295920871 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1295923763 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS1295929595 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS1295935628 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS1295942947 |
NOP56
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 36, Spinocerebellar ataxia type 36 |
| RS1295948508 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, 6 conditions |
| RS1295954187 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS1295957061 |
COL17A1
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta, Epidermolysis bullosa |
| RS1295968274 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1295969050 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome, Hereditary cancer-predisposing syndrome |
| RS1296005499 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1296009403 |
JPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Primary dilated cardiomyopathy |
| RS1296022681 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1296033854 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS1296034184 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1296034492 |
UPB1
|
Health Risk |
Pathogenic |
Deficiency of beta-ureidopropionase, Deficiency of beta-ureidopropionase |
| RS1296034886 |
LAMA3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1296034887 |
BAZ2B
|
Health Risk |
Likely pathogenic |
BAZ2B-related disorder, BAZ2B-related disorder |
| RS1296037862 |
ALDH7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1296042817 |
PDE6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 40, Retinal dystrophy |
| RS1296066077 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1296069449 |
AARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy, progressive |
| RS1296095311 |
ALOXE3
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 3 |
| RS1296112405 |
FOXI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1296153120 |
WASHC5
|
Health Risk |
Conflicting classifications of pathogenicity |
WASHC5-related disorder, Hereditary spastic paraplegia 8 |
| RS1296156738 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS1296165092 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Lamellar ichthyosis |
| RS1296165748 |
TYR
|
Health Risk |
Pathogenic |
— |
| RS1296189593 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1296191006 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1296209846 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1296227373 |
SUN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy, Emery-Dreifuss muscular dystrophy |
| RS1296234074 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS1296238058 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1296249274 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS1296262946 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1296268275 |
CYP21A2
|
Health Risk |
Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1296271407 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1296293849 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Inborn genetic diseases |
| RS1296301139 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1296301971 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1296322530 |
NEK1
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS1296345962 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1296348337 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration |
| RS1296353492 |
CIB1
|
Health Risk |
Pathogenic |
— |
| RS1296360030 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS1296378838 |
GCGR
|
Health Risk |
Pathogenic |
GCGR-related hyperglucagonemia, GCGR-related hyperglucagonemia |
| RS1296437426 |
WARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder |
| RS1296444163 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1296471018 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Autosomal recessive spastic paraplegia type 78, Kufor-Rakeb syndrome |
| RS1296477757 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
GATA2 deficiency with susceptibility to MDS/AML, Deafness-lymphedema-leukemia syndrome |
| RS1296485321 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS1296507371 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease type I, 7 conditions |
| RS1296511709 |
TOP3A
|
Health Risk |
Likely pathogenic |
— |
| RS1296531416 |
GLRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperekplexia, Hyperekplexia 1 |
| RS1296550753 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1296550963 |
CHAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS1296578005 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1296589338 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS1296595611 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS1296603906 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1296610881 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1296612982 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |